SwitchPoint Bio Holding, Inc. filed a Form D with the Securities and Exchange Commission on 2026-03-10.
SwitchPoint Bio Holding, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 10, 2026. The filing reports $5.27M sold. Its industry group is Biotechnology. It names Samuel Myllykangas (Executive Officer, Director), Jussi Paananen (Executive Officer, Director), David Proctor (Director) (SEC Form D, March 10, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like SwitchPoint Bio Holding, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-03-10 · the record
Pitching, partnering or investing alongside them? See who really runs and owns SwitchPoint Bio Holding, Inc.
Free to see. No signup.
More on the people and the money behind SwitchPoint Bio Holding, Inc., from the filings we hold.
Biotechnology raises by companies based in Delaware, filed within 90 days of this one, largest first.
Get an email when SwitchPoint Bio Holding, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when SwitchPoint Bio Holding, Inc. raises, hires or launches. No email unless you switch it on.
Watch SwitchPoint Bio Holding, Inc. →Get the full cited report on SwitchPoint Bio Holding, Inc.
What the filing shows about SwitchPoint Bio Holding, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on SwitchPoint Bio Holding, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives SwitchPoint Bio Holding, Inc.'s address as 251 Little Falls Drive, Wilmington, DE 19808.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on SwitchPoint Bio Holding, Inc. See pricing
SwitchPoint Bio Holding, Inc. is a registered filer with the SEC (CIK 2113353) and has filed since 2026-03-10. 1 filing is on record, the latest on 2026-03-10.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
SwitchPoint Bio Holding, Inc.'s Form D of 2026-03-10 names Samuel Myllykangas, Jussi Paananen and David Proctor as its officers, directors or promoters.
Its new offerings report $5.27M sold across 1 offering, as its own filings state.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $5.27M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Salaries
Samuel Myllykangas is named as Executive Officer and Director on the Form D that SwitchPoint Bio Holding, Inc. filed with the SEC on 10 March 2026, one of 3 people that filing names.
Jussi Paananen is named as Executive Officer and Director on the Form D that SwitchPoint Bio Holding, Inc. filed with the SEC on 10 March 2026, one of 3 people that filing names.
David Proctor is named as Director on the Form D that SwitchPoint Bio Holding, Inc. filed with the SEC on 10 March 2026, one of 3 people that filing names.
3 people named on the filing — 2 holding an executive role and 1 as a director only.
Named as of the 2026-03-10 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about SwitchPoint Bio Holding, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on SwitchPoint Bio Holding, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SwitchPoint Bio Holding, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist SwitchPoint Bio Holding, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind SwitchPoint Bio Holding, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for SwitchPoint Bio Holding, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Philadelphia
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/switchpoint-bio-holding-inc-form-d-26000001